Vinorelbine

colony stimulating factor 3 ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 26294015 Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. 2016 May 2
2 25891070 Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment. 2015 Jul 1
3 21663857 Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study. 2011 May 1
4 15613908 Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. 2005 Jan 1
5 15865083 Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer. 2005 Mar-Apr 1
6 11852999 Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer. 2002 2
7 12151959 Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies. 2002 Aug 1
8 11241232 Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma. 2001 Feb 15 2
9 11753545 Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma. 2001 Nov 1
10 10025378 Concurrent administration of vinorelbine with recombinant human granulocyte colony-stimulating factor: an effective method of increasing dose intensity. 1999 Feb 1
11 10334525 Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients. 1999 May 1
12 10509155 Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer. 1999 Aug 1
13 9720473 A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer. 1998 Aug 1
14 9193331 Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer. 1997 Apr 2
15 8610230 Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. 1996 Apr 1
16 7526467 Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor. 1994 Oct 3
17 7691117 Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer. 1993 1